www.cochrane.org Open in urlscan Pro
99.83.231.148  Public Scan

Form analysis
1 forms found in the DOM

POST /news/cochrane-who-executive-board-2024

<form id="search-form" action="/news/cochrane-who-executive-board-2024" method="post" accept-charset="UTF-8">
  <div>
    <div class="form-wrapper container-inline form-wrapper" id="edit-wrapper">
      <div class="form-item form-type-textfield form-item-keys">
        <input placeholder="Search..." class="as-keys form-autocomplete form-text jquery_placeholder-processed" type="text" id="edit-keys" name="keys" value="" size="20" maxlength="255">
      </div>
      <input class="as-submit form-submit" type="submit" id="edit-submit" name="op" value="Search">
    </div><input type="hidden" name="form_build_id" value="form-iwfBrlHLVyCQXHbHM8IgMfgbyU5qe5563o9ix2BXbGc">
    <input type="hidden" name="form_id" value="cochrane_reviews__search_form">
  </div>
</form>

Text Content

Jump to navigation


LANGUAGE:

 * English
 * Deutsch
 * Español
 * فارسی
 * Français
 * हिन्दी
 * Hrvatski
 * Magyar
 * Bahasa Indonesia
 * 日本語
 * 한국어
 * Bahasa Malaysia
 * Nederlands
 * Polski
 * Português
 * Română
 * Русский
 * தமிழ்
 * ภาษาไทย
 * 简体中文
 * 繁體中文

▼
More languages available
Show fewer languages
 * Media
 * Contact us
 * Community
 * My Account


COCHRANE

Trusted evidence.
Informed decisions.
Better health.


Cochrane Evidence Synthesis and Methods ►


COCHRANE AT THE WHO EXECUTIVE BOARD 2024

Last week, Cochrane participated in the 154th session of the World Health
Organization (WHO) Executive Board meeting in Geneva.

The Executive Board is composed of 34 technically qualified representatives from
different Member States, elected for three-year terms. Every January, the
Executive Board meets at WHO headquarters to discuss global public health
priorities for the year ahead and set the agenda for the World Health Assembly.

In addition to the Executive Board, all Member States and civil society
organizations in official relations with WHO, such as Cochrane, are given the
opportunity to contribute. This provided our delegation a great platform to
advocate for evidence-based health policy. 



The session began with an opening statement by WHO Director-General. He
highlighted the key achievements of the previous year, including the landmark
decision to include life-changing treatments for multiple sclerosis drugs in the
Essential Medicines List, which Cochrane Multiple Sclerosis and Rare Diseases of
the CNS played a key role in.

WHO’s 14th General Programme of Work (GPW14) was a major focus of this year’s
meeting. GPW14 is a medium-term strategy agreed by Member States and will
defines the direction of WHO’s work (including on evidence-based health) for
2025-28, with the goal to promote, provide, and protect health. 



Emma Thompson, Cochrane’s Advocacy and Partnerships Lead, made a statement in
front of Member States and WHO’s Director-General, speaking on behalf of
Cochrane in applauding the draft GPW’s recognition of WHO’s science and
evidence-based leadership, particularly highlighting the importance of
high-quality evidence in health decision making. 

In addition to the official planned activities at the Executive Board meeting,
Cochrane’s delegation used the opportunity to meet with several different WHO
departments to discuss plans for Cochrane’s Scientific Strategy, which is
currently in development, and opportunities for our next joint workplan.



Our delegation had many productive conversations with key individuals and teams
on how Cochrane and WHO can continue to work together to address global public
health priorities in the coming years. Supported by our years of relationship
building, collaboration and advocacy, we held meetings with many WHO teams,
covering a wide range of portfolios including maternal, newborn and child
health; essential medicines; malaria, tropical diseases; nutrition; clinical
trials; guidelines; health emergencies; and science. 



Another key highlight of the week was a meeting between Cochrane’s
Editor-in-Chief, Dr Karla Soares-Weiser, and the Director of the Pan American
Health Organization (PAHO), Dr Jarbas Barbosa and Dr Rhonda Sealey-Thomas, PAHO
Assistant Director. During the meeting, they discussed collaboration between
Cochrane and PAHO, which is underpinned by a new memorandum of understanding and
Dr Soares-Weiser highlighted Cochrane’s enthusiasm for the formalisation of this
partnership.

 * Find out more about the 154th session of the Executive Board

Thursday, February 1, 2024
 *  
   Was this helpful? Donate.
   If you found this evidence helpful, please consider donating to Cochrane. We
   are a charity that produces accessible evidence to help people make health
   and care decisions.
   Donate
 *  
   Print

Menu

 * Our evidence
 * About us
 * Join Cochrane
   * Cochrane Membership
   * Volunteer for Cochrane
   * Looking after our volunteers
   * Patients and carers
   * Cochrane Students
   * Cochrane Engage
   * Donate
 * News and jobs


LANGUAGE:

 * English
 * Deutsch
 * Español
 * فارسی
 * Français
 * हिन्दी
 * Hrvatski
 * Magyar
 * Bahasa Indonesia
 * 日本語
 * 한국어
 * Bahasa Malaysia
 * Nederlands
 * Polski
 * Português
 * Română
 * Русский
 * தமிழ்
 * ภาษาไทย
 * 简体中文
 * 繁體中文

More languages available
Show fewer languages
 * Media
 * Contact us
 * Community
 * My Account

Cochrane Library
►


OUR FUNDERS AND PARTNERS

 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 

◄ ►
See more
Cochrane
 * About Cochrane
   * Cochrane.org
   * Who we are
   * Get involved
   * Consumer Network
   * Partners
   * Colloquium
   * In the news
 * Publications
   * Cochrane Library
     * Cochrane Reviews (CDSR)
     * Trials (CENTRAL)
     * Cochrane Clinical Answers
   * Cochrane Evidence Synthesis and Methods
 * Community
   * Community
   * Cochrane Account
   * Training
   * Support
   * Methods
   * Software
   * Jobs and opportunities
 * Contact us
   * General enquiries
   * Cochrane Library support
   * Cochrane Groups
   * Media


Trusted evidence.
Informed decisions.
Better health.

Copyright © 2024 The Cochrane Collaboration
Index | Website Terms & Conditions | Disclaimer | Privacy | Cookie policy |
Cookie settings
We use cookies to improve your experience on our site. OK More information


OUR USE OF COOKIES

We use necessary cookies to make our site work. We'd also like to set optional
analytics cookies to help us improve it. We won't set optional cookies unless
you enable them. Using this tool will set a cookie on your device to remember
your preferences. You can always change your cookie preferences at any time by
clicking on the 'Cookies settings' link in the footer of every page.
For more detailed information about the cookies we use, see our Cookies page.

 * Necessary cookiesNecessary cookies enable core functionality such as
   security, network management, and accessibility. You may disable these by
   changing your browser settings, but this may affect how the website
   functions.
 * Legitimate interestWe'd like to set cookies so we can analyse our website
   usage with Matomo, to help us to improve our website and content. The data is
   anonymised and not shared with any third party. For more information see our
   Cookies page.

Accept all
Configure